疫苗接种后免疫力下降证明需要额外有效的COVID-19治疗。口咽粘膜局部免疫反应的免疫调节可以激活粘膜免疫,它可以在疾病的早期阶段预防SARS-CoV-2的主要免疫逃避机制,并向免疫系统的其他组成部分发出有效的警告。橄榄多酚是具有免疫调节活性的生物活性化合物。有以前的研究基于免疫调节与橄榄多酚和呼吸道感染使用肠内途径,这表明了对症状缓解时间的潜在影响。研究人员试图确定通过口腔粘膜途径给予少量高多酚橄榄油进行免疫调节后的参与者在COVID-19中是否会有更好的结果。
这项试点临床试验研究了颊咽给予高多酚橄榄油对COVID-19发病率的影响,持续时间,和严重性。
疫苗接种后免疫力下降,有必要进一步研究对COVID-19的其他有效治疗方法。
颊咽粘膜局部免疫反应的免疫调节可以激活粘膜免疫,这反过来会在疾病的早期阶段困难SARS-CoV-2免疫逃避机制,并向免疫系统的其他组成部分发出有效警告。橄榄多酚是具有免疫调节活性的生物活性化合物。以前有基于橄榄多酚和呼吸道感染的免疫调节的研究,使用肠内途径,这表明可能缩短症状消退的时间。研究人员试图确定通过口腔粘膜途径给予少量高多酚橄榄油进行免疫调节后的参与者在COVID-19中是否会有更好的结果。
双盲,在单一地点进行的随机试点临床试验,TalaveradelaReina,西班牙。在研究期间,通过简单随机抽样从最近诊断为COVID-19的接触患者的流行病学数据库中确定了潜在的研究参与者。共有88名成年参与者入组,84人完成了为期3个月的研究,在2021年7月1日至2022年8月31日期间进行。
参与者被随机分配接受口腔粘膜给药的高多酚橄榄油,2mL,每天2次,持续3个月或不治疗。
主要结果是发病率,持续时间,干预后COVID-19的严重程度。
两组之间的发病率没有差异,但持续时间有显著差异。高多酚橄榄油组症状缓解的中位时间为3天,而非治疗组为7天.尽管解决问题的时间与严重程度直接相关,这项研究未发现严重程度有任何差异.
在最近感染COVID-19的完全接种疫苗的成年人中,在感染前每天摄入少量的口腔粘膜服用高多酚橄榄油可显着改善症状缓解的时间。这一发现强烈支持了进一步深入研究高多酚橄榄油作为对抗COVID-19的有效免疫策略的适当性。
Waning immunity after vaccination justifies the need for additional effective COVID-19 treatments. Immunomodulation of local immune response at the oropharyngeal mucosa could hypothetically activate mucosal immunity, which can prevent SARS-CoV-2 main immune evasion mechanisms in early stages of the disease and send an effective warning to other components of immune system. Olive polyphenols are biologically active compounds with immunomodulatory activity. There are previous studies based on immunomodulation with olive polyphenols and respiratory infections using an enteral route, which point to potential effects on time to resolution of symptoms. The investigators sought to determine whether participants following immunomodulation with tiny quantities of high polyphenolic olive oil administered through an oromucosal route could have a better outcome in COVID-19.
This pilot clinical
trial investigated the effect of buccopharyngeal administered high polyphenolic olive oil on COVID-19 incidence, duration, and severity.
Waning immunity after vaccination justifies the need of further research for additional effective treatments for COVID-19.
Immunomodulation of local immune response at the buccopharyngeal mucosa could hypothetically activate mucosal immunity, which would in turn difficult SARS-CoV-2 immune evasion mechanisms in early stages of the disease and send an effective warning to other components of immune system. Olive polyphenols are biologically active compounds with immunomodulatory activity. There are previous studies based on immunomodulation with olive polyphenols and respiratory infections, using an enteral route, which suggest potential shortening of time to resolution of symptoms. The investigators sought to determine whether participants following immunomodulation with tiny quantities of high polyphenolic olive oil administered through an oromucosal route could have a better outcome in COVID-19.
Double blind, randomized pilot clinical
trial conducted at a single site, Talavera de la Reina, Spain. Potential study participants were identified by simple random sampling from the epidemiological database of contact patients recently diagnosed of COVID-19 during the
study period. A total of 88 adult participants were enrolled and 84 completed the 3-month
study, conducted between July 1, 2021 and August 31, 2022.
Participants were randomized to receive oromucosal administered high polyphenolic olive oil, 2 mL twice a day for 3 months or no treatment.
Primary outcomes were incidence, duration, and severity of COVID-19 after intervention.
There were no differences in incidence between both groups but there were significant differences in duration, the median time to resolution of symptoms was 3 days in the high polyphenolic olive oil group compared with 7 days in the no-treatment group. Although time to resolution is directly related to severity, this
study did not find any differences in severity.
Among full-vaccinated adults recent infected with COVID-19, a daily intake of tiny quantities of oromucosal administered high polyphenolic olive oil before infection significantly improved the time to symptom resolution. This finding strongly support the appropriateness of further deep research on the use of oromucosal administered high polyphenolic olive oil as an effective immune strategy against COVID-19.